Skip to content

Public FDA record

Z-1591-2021: VICI VENOUS STENT System Product Usage: is intended for the treatment of obstructions and occlusions in

Recall record Z-1591-2021 for Boston Scientific Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1591-2021
Company in FDA record
Boston Scientific Corporation
FDA record creation date
May 19, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

The firm has received reports of stent migration after implantation

Source facts

Action
Boston Scientific initiated the recall by letter on April 12, 2021. The letter requested the consignee cease use and further distribution of the affected product, segregate and return to Boston Scientific. Distributors were directed to further distribute the notice to their customers. For questions contact your local Sales Representative.
Initiated
2021-04-12
Root cause
Under Investigation by firm
Distribution
Worldwide - US Nationwide Distribution
Recall number
Z-1591-2021
Recall status
Open, Classified
CDRH record ID
186850
FDA record created
2021-05-19
Recall event number
87721

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗